Submit a Release
Home
All
ESG
Health
Technology
Finance
Contributors
Sub Menu
Submit a Release
main-search-pop
Main menu
Enzymatica AB: Invitation to Press Briefing - 5 March 2025
Contributed by:
PR Newswire
Tags
Enzymatica
More Like This
Enzymatica AB - Interim report Q3/2023: Research results that reshape the competitive landscape
Enzymatica AB's Interim report Q3/2024: Focus on developing existing and new markets
Enzymatica AB Year-end report 2024: Strong performance in core markets - preparing for international growth
Interim report Q2/2024: Enzymatica builds momentum for expansion
Enzymatica's Board of Directors decides on a new rights issue of approximately SEK 130 million
Enzymatica's Board of Directors decides on a new rights issue of SEK 27.4 million
Enzymatica's Board of Directors updates the financial targets
Year-end report 2023: Scientific and regulatory progress generating international interest